Literature DB >> 19775615

Chemotherapy in patients with castration-resistant prostate cancer.

Hielke J Meulenbeld1, Paul Hamberg, Ronald de Wit.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19775615     DOI: 10.1016/S0959-8049(09)70029-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  4 in total

1.  Anaemia and thrombocytopenia in patients with prostate cancer and bone metastases.

Authors:  Carsten Nieder; Ellinor Haukland; Adam Pawinski; Astrid Dalhaug
Journal:  BMC Cancer       Date:  2010-06-13       Impact factor: 4.430

2.  The experience with cytotoxic chemotherapy in metastatic castration-resistant prostate cancer.

Authors:  Mario A Eisenberger; Emmanuel S Antonarakis
Journal:  Urol Clin North Am       Date:  2012-11       Impact factor: 2.241

3.  Pathologic fracture and metastatic spinal cord compression in patients with prostate cancer and bone metastases.

Authors:  Carsten Nieder; Ellinor Haukland; Adam Pawinski; Astrid Dalhaug
Journal:  BMC Urol       Date:  2010-12-22       Impact factor: 2.264

4.  Androgen receptor as a driver of therapeutic resistance in advanced prostate cancer.

Authors:  Barbara Kahn; Joanne Collazo; Natasha Kyprianou
Journal:  Int J Biol Sci       Date:  2014-06-01       Impact factor: 6.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.